Position
Bridgewater in BridgeBio Pharma, Inc.
Back to the book · All holders of BBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $57.1K$74.26 → $74.48
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 43.2K | $3.3M | — | — | — | 0.0% |
| Q1 2026 | 259.5K | $19.3M | $74.26 | −$96.3K | $16.1M | 0.1% |
| Q2 2026 | 448.1K | $33.4M | $74.48 | $57.1K | $14.1M | 0.1% |